Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 13 - Number 5



Natural Products and Transforming Growth Factor-beta (TGF-β) Signaling in Cancer Development and Progression

, 13(5): 500 - 505

Chung Lee, Qiang Zhang, James Kozlowski, Charles Brendler, Marcelo B. Soares, Atrya Dash, Michael McClelland and Dan Mercola


DOI: 10.2174/15680096113139990034



miRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents

, 13(5): 519 - 541

Biyun Qian, Subhasree A. Nag, Yuliang Su, Sukesh Voruganti, Jiang-Jiang Qin, Ruiwen Zhang and William C. S. Cho


DOI: 10.2174/15680096113139990031



Histone Lysine-Specific Methyltransferases and Demethylases in Carcinogenesis: New Targets for Cancer Therapy and Prevention

, 13(5): 558 - 579

Xuejiao Tian, Saiyang Zhang, Hong-Min Liu, Yan-Bing Zhang, Christopher A. Blair, Dan Mercola, Paolo Sassone-Corsi and Xiaolin Zi


DOI: 10.2174/1568009611313050007





Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

Oct-2021-ban

Related Journals

Related eBooks

eBooks Catalog